- identity (MS)
- purity (HPLC)
- net content
- endotoxin
- sterility (USP <71>)
- heavy metals
GIP/GLP-1/glucagon triple agonist · GLP-1 · research compound
Retatrutide 30mg for sale: research prices from 2 vendors
For research use only. Price before shipping and tax. Affiliate link: it never affects grades or order.
Retatrutide 30mg vials cost from $229.99 ($7.67/mg) at LA Peptides, observed 14 Nov 2026, and 2 vendors have current prices for this package. Across 5 sizes in stock, prices run from $6.25/mg (48mg) to $10.50/mg (10mg). US-dollar list prices before shipping, tax and unverified codes. These are research-use package prices, not clinic or monthly prescription costs.
Investigational: phase 3 trial results are published, no regulator has approved retatrutide as of 5 Nov 2026, and Lilly plans a US submission in Q1 2027 (a plan, not a launch date).
ranked by use case · prices read in the last 7 days · no supplier pays for a place
Where to buy Retatrutide 30mg
2 suppliers have Retatrutide in stock at a price read in the last 7 days. PeptideTech names no single best supplier: the list is ranked by price per mg for 30mg, and the leader for each use case is marked.
- best valueLA Peptides$7.67/mg for 30mg · price read 14 Nov 2026
- best documentedAmerican Peptidesvendor grade 71/100 · from lab documents and records, never paid
- most sizes in stockAmerican Peptides4 sizes at a current price
| rank | supplier | package | price | per mg | vendor grade | sizes in stock | price read | supplier link |
|---|---|---|---|---|---|---|---|---|
| rank 1 | LA Peptides | 1 vial · 30mg labelled | $229.99 | $7.67/mg | 3 sizes | view offer, Retatrutide 30mg at LA Peptides, opens in a new tab | ||
| rank 2 | American Peptides | 1 vial · 48mg labelled no 30mg in stock | $300.00 | $6.25/mg | 4 sizes | view offer, Retatrutide 48mg at American Peptides, opens in a new tabcopies code TECH10 |
How it is ranked. Suppliers with 30mg in stock come first, cheapest price per mg first; a supplier without it follows with its cheapest current package. Best documented is the PeptideTech vendor grade (rubric v0.6), computed from lab documents, business records and service terms; no supplier can pay for a grade or a place, and the featured partner gets no extra place here. Most sizes counts the sizes in stock at a current price. Prices are listed prices before codes, shipping and tax; a price older than 7 days is left out. how supplier evidence is assessed
sorted by price · 30mg · prices before codes and shipping · checked 17 Nov 2026
Retatrutide 30mg offers
research market · not for human use
- identity (MS)
- purity (HPLC)
- net content
- endotoxin
- heavy metals
Prices are each vendor’s listed price before shipping, unless a verified code is marked as included. Some outbound links are affiliate links and PeptideTech keeps a fee from sellers on checkout orders; neither affects grades or scores, or order apart from the labelled featured partner. PeptideTech does not test products. Certificates of analysis are the seller’s or the lab’s documents, attributed to them, and PeptideTech does not verify them unless a specific record says so. Report a seller
one exact package · 1 vial · 30mg labelled · US dollars before shipping and tax
Retatrutide 30mg supplier comparison
| supplier | package | price (USD) | per mg | status | observed | code terms | lot certificate |
|---|---|---|---|---|---|---|---|
| LA Peptides evidence profile | 1 vial · 30mg labelled | $229.99 | $7.67/mg | current · in stock | 14 Nov 2026 | no code | Bioviridian Inc. · 20 Oct 2026 · lot 1918 |
| American Peptides evidence profile | 1 vial · 30mg labelled | $240.00 | $8.00/mg | current · out of stock | 17 Nov 2026 | code TECH10 carried by our link; not deducted (discount unverified) | Bioviridian Inc. · 17 Aug 2026 · lot RETA30-0803 |
| Blank Peptides evidence profile | 1 vial · 30mg labelled | $239.00 | $7.97/mg | historical | 30 Sep 2026 | code PEPTECH carried by our link; not deducted (discount unverified) | none matched |
- Package. Every row is a single vial (1 vial · 30mg labelled); multi-vial packs, kits and bundles are left off this comparison.
- Price scope. Each vendor’s listed item price in US dollars for the US market, before shipping and sales tax, which its checkout sets. A code is deducted only when its discount was verified in a cart. These are research-use package prices, not clinic, prescription or monthly programme costs.
- Current or historical. A price is current when its source was read in the last seven days; historical rows are older listings, kept with their date and left out of the lowest price and the structured data.
How offers are selected
- Every row is one exact package: 30mg, one form, US market, US-dollar price as the vendor lists it.
- Vials, multi-vial packs, bundles, pens, sprays and blends stay in separate comparisons; kits and subscriptions are left out.
- Offers are ranked by displayed price; a code is included only when its discounted price was verified in a cart. A referral code is not a confirmed discount.
- A price is current when its source was read in the last 7 days; older listings stay visible as historical and are excluded from the lowest price. Read each offer’s source date, stock, currency and market.
- A catalogue name or alias (a vendor code name) is the seller’s claim: check it against the product specification and the lot report.
- Grades come from lab documents, business records and service terms, scored the same way for every vendor; no vendor can pay for a grade or rank.
Grading rubric, sources and corrections: how supplier evidence is assessed.
Other packages side by side, with each size’s lowest current price: compare all Retatrutide sizes and suppliers.
every size · lowest current in-stock price · US dollars before shipping
Retatrutide price by size
| size | package | from | per mg | cheapest vendor | observed | availability |
|---|---|---|---|---|---|---|
| Retatrutide 10mg price | 1 vial · 10mg labelled | $94.99 | $9.50/mg | LA Peptides | 14 Nov 2026 | 2 in stock |
| Retatrutide 15mg price | 1 vial · 15mg labelled | — | — | — | — | historical · last $119.00 at Blank Peptides, 30 Sep 2026 |
| Retatrutide 20mg price | 1 vial · 20mg labelled | $169.99 | $8.50/mg | LA Peptides | 14 Nov 2026 | 2 in stock |
| Retatrutide 30mg price this page | 1 vial · 30mg labelled | $229.99 | $7.67/mg | LA Peptides | 14 Nov 2026 | 1 in stock |
| Retatrutide 48mg price | 1 vial · 48mg labelled | $300.00 | $6.25/mg | American Peptides | 17 Nov 2026 | 1 in stock |
| Retatrutide 60mg price | 1 vial · 60mg labelled | $400.00 | $6.67/mg | American Peptides | 17 Nov 2026 | 1 in stock |
This page compares 30mg; the Retatrutide page compares its default package, and every size opens its own supplier comparison. Prices exclude shipping and tax.
in-stock offers · every size · per mg before codes and shipping
what it costs
Dated observations, daily medians and CSV or JSON downloads for this package: Retatrutide price history and methodology.
this page compares 30mg only
more on Retatrutide
Evidence, lab results, legal status and storage cover every size and are on the Retatrutide page.
- Retatrutide: every size and supplierthe compound page
- Retatrutide lab results9 lot certificates read
- Retatrutide research profilemechanism, studies, evidence grade
- Retatrutide calculatorvial and diluent arithmetic
- Retatrutide vs Tirzepatide
- Retatrutide vs Semaglutide
short answers
Retatrutide 30mg questions
How much does Retatrutide cost?
Where is the cheapest place to buy Retatrutide?
Is the Retatrutide 30mg price for one vial or several?
How is the Retatrutide 30mg price per mg calculated?
What sizes of Retatrutide are available?
Are the Retatrutide prices and discount codes current?
Which Retatrutide coupon codes work?
Is Retatrutide FDA approved?
Has Retatrutide been tested in clinical trials?
Is Retatrutide legal to buy?
Is the Retatrutide price a clinic or monthly cost?
Can you purchase retatrutide?
Do you need a prescription for retatrutide?
Is retatrutide the same as Ozempic?
What is the price of retatrutide 10mg in the USA?
Retatrutide price history
Actual source observations from the last 14 days, shown separately by supplier, package and currency. Missing days are not filled in. The first refresh can preserve an earlier recorded price; it does not establish a daily price history.
| Observed (UTC) | Supplier | Package | Price | Stock |
|---|---|---|---|---|
| 2026-11-17 07:50 | American Peptides | 30mg · Vial | $240.00 | Out of stock |
| 2026-11-16 08:02 | American Peptides | 30mg · Vial | $240.00 | In stock |
| 2026-11-15 07:50 | American Peptides | 30mg · Vial | $240.00 | In stock |
| 2026-11-14 07:51 | LA Peptides | 30mg · Vial | $229.99 | In stock |
| 2026-11-14 07:49 | American Peptides | 30mg · Vial | $240.00 | In stock |
| 2026-11-13 07:52 | LA Peptides | 30mg · Vial | $229.99 | In stock |
| 2026-11-13 07:50 | American Peptides | 30mg · Vial | $240.00 | In stock |
| 2026-11-12 07:50 | American Peptides | 30mg · Vial | $240.00 | In stock |
| 2026-11-11 07:49 | American Peptides | 30mg · Vial | $240.00 | In stock |
| 2026-11-10 07:50 | American Peptides | 30mg · Vial | $240.00 | In stock |
| 2026-11-09 07:50 | American Peptides | 30mg · Vial | $240.00 | Out of stock |
| 2026-11-08 07:49 | American Peptides | 30mg · Vial | $240.00 | In stock |
Research reference
Selected sources reviewed
Retatrutide, also identified as LY3437943, is an investigational agonist at GIP, GLP-1 and glucagon receptors. A peer-reviewed phase 2 trial and a later sponsor-described phase 3 program are different levels of source evidence.[1][2]
Identity checks
“Triple agonist” names the three receptor targets; it does not identify a separate “GLP-3” receptor or authenticate a product sold under that nickname.[1][2]
Published phase 2 evidence; phase 3 sponsor updates
The published randomized phase 2 trial enrolled 338 adults. Lilly’s current information describes an investigational phase 3 development program. Sponsor updates are identified as sponsor information, not substituted for a peer-reviewed paper or regulatory approval.[1][2]
Regulatory context
Drugs@FDA lists no NDA, BLA or ANDA with retatrutide as an active ingredient (names searched: RETATRUTIDE, LY3437943; checked October 7, 2026). Research-labelled Retatrutide listings are not FDA-approved drugs.
Sources: Drugs@FDA active-ingredient search: RETATRUTIDE, LY3437943 · checked
FDA states that retatrutide is not a component of an FDA-approved drug. Lilly describes it as investigational. This review does not infer regulatory status for every country.[3][2]
Supporting sources
- Retatrutide for obesity: a randomized phase 2 trialNew England Journal of Medicine · PubMed record · checked
- What to know about retatrutideEli Lilly and Company · trial sponsor · checked
- FDA concerns with unapproved GLP-1 drugs used for weight lossU.S. Food and Drug Administration · checked
Research searches — not supporting citations
Search results may include unrelated records. A search link does not establish that a matching study exists.
These selected sources describe named substances and studied formulations. They do not authenticate a supplier, a certificate of analysis or the contents of a particular lot, and do not provide instructions for use. “Healing” and other catalogue categories are navigation labels, not evidence of efficacy or treatment recommendations.
Retatrutide research and reading
Read the evidence, identity checks and limitations alongside the catalogue. Research findings do not verify a vendor’s product or establish suitability for personal use.
Retatrutide Storage: Powder, Solutions & Evidence Limits
What each retatrutide supplier actually states about storing the powder and a solution, what stability evidence exists, and why no shelf life can be taken from other peptides.
Updated Nov 5, 2026Retatrutide Approval Status, Availability & Trial Updates
Is retatrutide FDA approved? A dated status box, the approval-versus-trial timeline, a registry table and the phase 3 papers published so far, with unknowns stated plainly.
Updated Nov 5, 2026Retatrutide, Tirzepatide & Semaglutide: Evidence Compared
A three-way matrix of receptor targets, authorization status and trials, plus which pairs have head-to-head evidence and why separate trial results cannot be ranked.
Updated Nov 5, 2026Save Retatrutide
Bookmark this product in your browser. To keep a particular supplier, size and form, use “Save offer” beside a price. Neither feature sends alerts or creates a subscription.